# Carisma Therapeutics, Inc. (CARM) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/CARM
## Company Profile
- Ticker: CARM
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Immunotherapy, Oncology
## Stock Data
- Close: 0.0007 USD
- Market cap: Not available USD
- Last updated: 2026-09-04
## Business Overview
Carisma Therapeutics is a cell-therapy company focused on engineered macrophages and cancer immunotherapy. Its story centers on using a novel immune-cell approach to attack tumors.
## Why The Stock Is Moving

As of Sep 4, 2026, CARM closed down 22.2% at $0.0007. No new same-company headline was identified in the current news window.

## Geographic Base

Carisma is headquartered in the United States and listed on NASDAQ. It sits in cell therapy and oncology biotechnology.

## Business Model

The company depends on clinical validation, manufacturing feasibility, and capital support while it advances a narrow pipeline. Investors watch early data and platform differentiation.

## Landscape Position

Carisma occupies a specialized macrophage-cell-therapy niche within biotech. It is catalyst-sensitive because the platform still needs to prove itself clinically.

## Future Catalysts

- Carisma’s catalysts are macrophage-engineering programs and any strategic or clinical update that clarifies the company’s next path. The company still needs stronger human proof.

## Recent News
- 2025-12-05 16:16 EST — [Carisma Announces Delisting from Nasdaq and SEC Deregistration](https://biopharmsignal.com/news/CARM/carisma-announces-delisting-from-nasdaq-and-sec-deregistration) — Source: Carisma Therapeutics, Inc.
- 2025-03-31 20:30 EST — [Carisma Therapeutics Provides Corporate Updates](https://biopharmsignal.com/news/CARM/carisma-therapeutics-provides-corporate-updates) — Source: Carisma Therapeutics, Inc.
- 2025-02-19 12:30 EST — [Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference](https://biopharmsignal.com/news/CARM/carisma-therapeutics-to-participate-in-h-c-wainwright-3rd-annual-cell-therapy-virtual-conference) — Source: Carisma Therapeutics, Inc.
- 2025-02-05 12:30 EST — [Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference](https://biopharmsignal.com/news/CARM/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference) — Source: Carisma Therapeutics, Inc.
- 2024-12-09 13:30 EST — [Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline](https://biopharmsignal.com/news/CARM/carisma-therapeutics-announces-strategic-restructuring-to-re-prioritize-pipeline) — Source: Carisma Therapeutics, Inc.